Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Target Discovery For Anticancer Therapy Facilitated By Artificial Intelligence PDF full book. Access full book title Target Discovery For Anticancer Therapy Facilitated By Artificial Intelligence.
| Author | : Feng Zhu |
| Publisher | : Frontiers Media SA |
| Total Pages | : 218 |
| Release | : 2021-08-19 |
| Genre | : Science |
| ISBN | : 2889712001 |
| Author | : John Cassidy |
| Publisher | : BoD – Books on Demand |
| Total Pages | : 194 |
| Release | : 2020-09-09 |
| Genre | : Medical |
| ISBN | : 1789846897 |
There exists a profound conflict at the heart of oncology drug development. The efficiency of the drug development process is falling, leading to higher costs per approved drug, at the same time personalised medicine is limiting the target market of each new medicine. Even as the global economic burden of cancer increases, the current paradigm in drug development is unsustainable. In this book, we discuss the development of techniques in machine learning for improving the efficiency of oncology drug development and delivering cost-effective precision treatment. We consider how to structure data for drug repurposing and target identification, how to improve clinical trials and how patients may view artificial intelligence.
| Author | : Ariel Fernandez |
| Publisher | : World Scientific |
| Total Pages | : 469 |
| Release | : 2021-03-12 |
| Genre | : Science |
| ISBN | : 9811232326 |
In the era of big biomedical data, there are many ways in which artificial intelligence (AI) is likely to broaden the technological base of the pharmaceutical industry. Cheminformatic applications of AI involving the parsing of chemical space are already being implemented to infer compound properties and activity. By contrast, dynamic aspects of the design of drug/target interfaces have received little attention due to the inherent difficulties in dealing with physical phenomena that often do not conform to simplifying views.This book focuses precisely on dynamic drug/target interfaces and argues that the true game change in pharmaceutical discovery will come as AI is enabled to solve core problems in molecular biophysics that are intimately related to rational drug design and drug discovery.Here are a few examples to convey the flavor of our quest: How do we therapeutically impair a dysfunctional protein with unknown structure or regulation but known to be a culprit of disease? In regards to SARS-CoV-2, what is the structural impact of a dominant mutation?, how does the structure change translate into a fitness advantage?, what new therapeutic opportunity arises? How do we extend molecular dynamics simulations to realistic timescales, to capture the rare events associated with drug targeting in vivo? How do we control specificity in drug design to selectively remove side effects? This is the type of problems, directly related to the understanding of drug/target interfaces, that the book squarely addresses by leveraging a comprehensive AI-empowered approach.
| Author | : Nathan Brown |
| Publisher | : Royal Society of Chemistry |
| Total Pages | : 425 |
| Release | : 2020-11-04 |
| Genre | : Computers |
| ISBN | : 1839160543 |
Following significant advances in deep learning and related areas interest in artificial intelligence (AI) has rapidly grown. In particular, the application of AI in drug discovery provides an opportunity to tackle challenges that previously have been difficult to solve, such as predicting properties, designing molecules and optimising synthetic routes. Artificial Intelligence in Drug Discovery aims to introduce the reader to AI and machine learning tools and techniques, and to outline specific challenges including designing new molecular structures, synthesis planning and simulation. Providing a wealth of information from leading experts in the field this book is ideal for students, postgraduates and established researchers in both industry and academia.
| Author | : Adam Bohr |
| Publisher | : Academic Press |
| Total Pages | : 385 |
| Release | : 2020-06-21 |
| Genre | : Computers |
| ISBN | : 0128184396 |
Artificial Intelligence (AI) in Healthcare is more than a comprehensive introduction to artificial intelligence as a tool in the generation and analysis of healthcare data. The book is split into two sections where the first section describes the current healthcare challenges and the rise of AI in this arena. The ten following chapters are written by specialists in each area, covering the whole healthcare ecosystem. First, the AI applications in drug design and drug development are presented followed by its applications in the field of cancer diagnostics, treatment and medical imaging. Subsequently, the application of AI in medical devices and surgery are covered as well as remote patient monitoring. Finally, the book dives into the topics of security, privacy, information sharing, health insurances and legal aspects of AI in healthcare. Highlights different data techniques in healthcare data analysis, including machine learning and data mining Illustrates different applications and challenges across the design, implementation and management of intelligent systems and healthcare data networks Includes applications and case studies across all areas of AI in healthcare data
| Author | : Quentin Vanhaelen |
| Publisher | : Humana |
| Total Pages | : 0 |
| Release | : 2018-12-14 |
| Genre | : Medical |
| ISBN | : 9781493989546 |
This detailed book explores techniques commonly used for research into drug repurposing, a well-known strategy to find alternative indications for drugs which have already undergone toxicology and pharma-kinetic studies but have failed later stages during the development, via computational methods. Thereby, it addresses the intense challenges of identifying the appropriate type of algorithm and relevant technical information for computational repurposing. Written for the highly successful Methods in Molecular Biology series, the authors of each chapter use their experience in the field to describe the implementation and successful use of a specific repurposing method thus providing lab-ready instruction. Authoritative and practical, Computational Methods for Drug Repurposing serves as an ideal guide to researchers interested in this vital area of drug development.
| Author | : Beverley Isherwood |
| Publisher | : Royal Society of Chemistry |
| Total Pages | : 273 |
| Release | : 2020-12-09 |
| Genre | : Medical |
| ISBN | : 1839160799 |
Phenotypic drug discovery has been highlighted in the past decade as an important strategy in the discovery of new medical entities. How many marketed drugs are derived from phenotypic screens? From the most recent examples, what were the factors enabling target identification and validation? This book answers these questions by elaborating on fundamental capabilities required for phenotypic drug discovery and using case studies to illustrate approaches and key success factors. Written and edited by experienced practitioners from both industry and academia, this publication will equip researchers with a thought-provoking guide to the application and future development of contemporary phenotypic drug discovery for clinical success.
| Author | : Jaber, Wassim |
| Publisher | : IGI Global |
| Total Pages | : 313 |
| Release | : 2023-12-07 |
| Genre | : Technology & Engineering |
| ISBN | : |
In the world of academia, scholars and researchers are confronted with a rapidly expanding knowledge base in Artificial Intelligence (AI) and nanotechnology. The integration of these two groundbreaking fields presents an intricate web of concepts, innovations, and interdisciplinary applications that can overwhelm even the most astute academic minds. Staying up to date with the latest developments and effectively navigating this complex terrain has become a pressing challenge for those striving to contribute meaningfully to these fields. Artificial Intelligence in the Age of Nanotechnology is a transformative solution meticulously crafted to address the academic community's knowledge gaps and challenges. This comprehensive book serves as the guiding light for scholars, researchers, and students grappling with the dynamic synergy between AI and Nanotechnology. It offers a structured and authoritative exploration of the core principles and transformative applications of these domains across diverse fields. By providing clarity and depth, it empowers academics to stay at the forefront of innovation and make informed contributions.
| Author | : Alexander Heifetz |
| Publisher | : |
| Total Pages | : 529 |
| Release | : 2021 |
| Genre | : Artificial intelligence |
| ISBN | : 9781071617878 |
This volume looks at applications of artificial intelligence (AI), machine learning (ML), and deep learning (DL) in drug design. The chapters in this book describe how AI/ML/DL approaches can be applied to accelerate and revolutionize traditional drug design approaches such as: structure- and ligand-based, augmented and multi-objective de novo drug design, SAR and big data analysis, prediction of binding/activity, ADMET, pharmacokinetics and drug-target residence time, precision medicine and selection of favorable chemical synthetic routes. How broadly are these approaches applied and where do they maximally impact productivity today and potentially in the near future. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary software and tools, step-by-step, readily reproducible modeling protocols, and tips on troubleshooting and avoiding known pitfalls. Cutting-edge and unique, Artificial Intelligence in Drug Design is a valuable resource for structural and molecular biologists, computational and medicinal chemists, pharmacologists and drug designers.
| Author | : Rishabha Malviya |
| Publisher | : Springer Nature |
| Total Pages | : 949 |
| Release | : 2023-04-11 |
| Genre | : Science |
| ISBN | : 9811997861 |
This book highlights the role of Biomedical Engineering (BME) used in diagnosis (e.g., body scanners) and treatment (radiation therapy and minimal access surgery in order to prevent various diseases). In recent years, an important progress has been made in the expansion of biomedical microdevices which has a major role in diagnosis and therapy of cancer. When fighting cancer, efficacy and speed are of the utmost importance. A recently developed microfluidic chip has enabled a breakthrough in testing the efficacy of specialized cancer drugs. Effective cancer-targeting therapies will require both passive and active targeting strategies and a thorough understanding of physiologic barriers to targeted drug delivery. Targeted cancer treatments in development and the new combinatorial approaches show promise for improving targeted anticancer drug delivery and improving treatment outcomes. This book discusses the advancements and innovations in the field of BME that improve the diagnosis and treatment of cancer. This book is focused on bioengineering approaches to improve targeted delivery for cancer therapeutics, which include particles, targeting moieties, and stimuli-responsive drug release mechanisms. This book is a useful resource for students, researchers, and professionals in BME and medicine.
